Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

719 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
Bennett JM, Young MS, Liesveld JL, Paietta E, Miller KB, Lazarus HM, Marsh RD, Friedenberg WR, Saba HT, Hayes FA, Dewald GW, Hiddemann W, Rowe JM. Bennett JM, et al. Am J Hematol. 2001 Jan;66(1):23-7. doi: 10.1002/1096-8652(200101)66:1<23::AID-AJH1002>3.0.CO;2-B. Am J Hematol. 2001. PMID: 11426487 Free article. Clinical Trial.
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.
Cripe LD, Rader K, Tallman MS, Gordon MS, Paietta E, Bennett J, Neuberg D, Litzow MR, O'brien TE, Rowe JM. Cripe LD, et al. Among authors: bennett j. Leuk Res. 2006 Jul;30(7):823-7. doi: 10.1016/j.leukres.2005.11.006. Epub 2006 Jan 18. Leuk Res. 2006. PMID: 16413056 Clinical Trial.
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).
Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH. Rowe JM, et al. Among authors: bennett jm. Blood. 1995 Jul 15;86(2):457-62. Blood. 1995. PMID: 7605984 Free article. Clinical Trial.
Hypocellular myelodysplastic syndromes (MDS): new proposals.
Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM. Tuzuner N, et al. Among authors: bennett jm. Br J Haematol. 1995 Nov;91(3):612-7. doi: 10.1111/j.1365-2141.1995.tb05356.x. Br J Haematol. 1995. PMID: 8555063
719 results